Last reviewed · How we verify

NCT06626854

Treating Chronic Pain of Peripheral Nerve Origin With the Novel Noninvasive Hypersound Neuromodulation System

Not yet recruiting EARLY_PHASE1 Last updated 23 February 2026
What this trial tests

EARLY_PHASE1 trial testing RF-PNS in Chronic Knee Pain in 5 participants. Not yet recruiting.

Timeline
10 June 2026
Primary endpoint
10 October 2026
10 December 2026

Quick facts

Lead sponsorHypersound Medical Inc
PhaseEARLY_PHASE1
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment5
Start date10 June 2026
Primary completion10 October 2026
Estimated completion10 December 2026

Drugs / interventions tested

Conditions studied

Sponsor

Hypersound Medical Inc

Who can join

Adults 18 to 75, any sex, with Chronic Knee Pain or Chronic Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

First, the subject will undergo screening and provide informed consent. Baseline measurements are then taken. The subject remains seated with back support throughout the session. The technician verifies and marks the knee for treatment and wraps an antenna applicator strap around the lower leg near the knee. The device is turned on in test mode to confirm the therapy location, with the subject identifying when they feel a sensation over their pain area. The power threshold for this sensation is recorded. The therapy, which lasts 15 minutes, is delivered at 90% of this threshold to ensure the subject does not feel it. After therapy, post-treatment measurements are taken.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Knee Pain

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06626854.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing